|
|
|
 Wednesday, January 23, 2013 Prosper Finds $20M In Funding, Sets New CEO San Francisco-based peer-to-peer lending marketplace Prosper said Tuesday that it has raised $20M in a funding round from Sequoia Capital, and also named a new CEO. Prosper said it has named Pat Grady of Sequoia Capital to its board of directors with the funding; the company also has named Stephan Vermut as its CEO and member of its board. Vermut it the former founder and managing partner of Merlin Securities. posted on Wednesday, January 23, 2013 (More)(Full story) Yahoo Buys Snip.it San Francisco-based Snip.it, the developer of a social tool for sharing web pages, news, and other information with others, has been acquired by Yahoo. Financial terms of the acquisition were not disclosed. Snip.it said it would be shutting down its service as of today due to the acquisition, and allow users to export their content. The company said, in a post on its site, that it will be taking "social news to new (More info...) posted on Wednesday, January 23, 2013(Full story) Cisco Buys Intucell San Jose-based Cisco said today that it is acquiring Intucell, an Israeli developer of advanced self-optimizing network (SON) software, used for managing, configuring, and automatically healing cellular networks. Cisco said it will pay $475M in cash and retention-based incentives for Intucell. Cisco said the buy adds a "critical network intelligence layer" for the network of mobile operators. posted on Wednesday, January 23, 2013(Full story) AppDynamics Snags $50M San Francisco-based AppDynamics, the developer of application performance management software, said today that it has raised $50M in a Series D round. The growth funding was led by new investor Institutional Venture Partners, and also included prior investors Greylock Partners, Kleiner Perkins Caufield & Byers, and Lightspeed Venture Partners. AppDynamics, which is headed by Jyoti Bansal, said it will use the funding for expansion into the global e (More info...) posted on Wednesday, January 23, 2013 (More)(Full story) MAP Pharmaceuticals Acquired By Allergan Mountain View-based MAP Pharmaceuticals, a publicly held developer of biopharmaceuticals aimed at treating migraines in adults, has been acquired by Allergan. The two said that Allergan will pay $25.00 per share for MAP, or approximately $958M, in the deal. Allergan was advised by Goldman, Sachs & Co. and Gibson, Dunn & Crutcher LLP in the deal; MAP Pharmaceuticals was advised by Centerview Partners LLC a (More info...) posted on Wednesday, January 23, 2013(Full story)
|
|
